Brind.
  1. Onsemi is planning to acquire Synaptics for $7 billion, and a Synaptics board member has joined the Onsemi board.

onsemi Faces Integration Risk Amid Synaptics Deal Renegotiation

3 reports, 2 independent Updated Tue 00:00
No new developments lately
Reports
3
Developments
2
Repetition
33%

New informationRepeats or wire copies

AI-generated briefing. Brind wrote this from the reports listed below and has updated it as the story developed. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Jim Cramer rated onsemi as a laggard stock following the renegotiation of the Synaptics acquisition. On October 13, 2026, reports noted that onsemi faces integration risk related to the Synaptics deal. Despite this, onsemi reported second-quarter 2026 revenue of approximately $1.60 billion, which exceeded estimates.

From 247wallst.com, insidermonkey.com

Why it matters

Some supportBrind's analysis of the reports

The acquisition of Synaptics for $7 billion is a major strategic move for onsemi. Analysts are considering the stock's recovery potential, citing growing demand from AI infrastructure and management's projection that AI data center revenue will more than double in 2026.

onsemi is planning to acquire Synaptics for $7 billion, and a Synaptics board member has joined the onsemi board.

From insidermonkey.com

Who's involved

  • onsemiSemiconductor company planning the acquisition of Synaptics.
  • SynapticsTechnology company being acquired by onsemi.

How it developed

Newest first. Tap a step to see who reported it.
  1. ON Semiconductor faces integration risk related to the Synaptics deal.1 source
  2. Cramer rates ON as a laggard stock amid Synaptics deal renegotiation.1 source

Keep exploring

Part of

Onsemi is planning to acquire Synaptics for $7 billion, and a Synaptics board member has joined the Onsemi board. All 1 developments

The entities involved

Coverage

Newest first; wire copies grouped